Virus-host immune interaction in asymptomatic HTLV-1 carriers

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Human T-cell leukemia virus type 1 (HTLV-1) establishes chronic infections, often asymptomatic but can lead to fatal diseases like adult T-cell leukemia.
• Viral production is minimal during the latent phase, and the precise virus-host immune interactions remain incompletely understood.
• Higher proviral loads in asymptomatic carriers are linked to increased disease progression risk.

Purpose of the Study:

• To investigate virus-specific antibody and T-cell responses in asymptomatic HTLV-1 carriers.
• To elucidate the mechanisms of virus-host immune interaction during latent HTLV-1 infection.

Main Methods:

• Analysis of neutralizing antibody levels and anti-Env SU (gp46) antibodies in 77 asymptomatic HTLV-1 carriers.
• Ex vivo culture of peripheral blood mononuclear cells to assess HTLV-1 Gag antigen (p19) expression in CD4+ T cells and interferon-gamma (IFN-γ) induction in CD8+ T cells.
• Correlation analysis of immune responses with proviral loads and T-cell frequencies.

Main Results:

• Neutralizing antibody responses positively correlated with proviral loads and anti-Env SU antibody levels.
• Detectable HTLV-1 Gag (p19) expression in CD4+ T cells and IFN-γ induction in CD8+ T cells were observed ex vivo.
• Frequencies of p19-expressing CD4+ T cells and IFN-γ-induced CD8+ T cells correlated positively with proviral loads.
• Tax-specific CD8+ T-cell frequencies inversely correlated with the ratio of p19-expressing CD4+ T cells to proviral loads, suggesting a regulatory role.

Conclusions:

• Tax-specific CD8+ T-cell responses appear crucial in controlling HTLV-1 replication during latent infection.
• Understanding these immune interactions provides insights into managing HTLV-1 infection and preventing disease progression.